CARA - Cara Therapeutics Inc.'s (CARA) CEO Derek Chalmers on Q4 2020 Results - Earnings Call Transcript
Cara Therapeutics, Inc. (CARA) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Jack Hildick-Smith - Stern IR Derek Chalmers - Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Avatar Jones - Stifel Financial Corp. Brian Mills - Jefferies Jason Gerberry - Bank of America Merrill Lynch Joseph Stringer - Needham & Company David Amsellem - Piper Sandler Benedict Shim - Canaccord Genuity LLC Presentation Operator Good afternoon and welcome to Cara Therapeutics' Fourth Quarter and Full Year 2020 Financial Results Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request. I would now like to turn the call over to Cara team. Please proceed. Jack Hildick-Smith Good afternoon. This is Jack Hildick-Smith with Stern Investor Relations and welcome to Cara Therapeutics'
For further details see:
Cara Therapeutics, Inc.'s (CARA) CEO Derek Chalmers on Q4 2020 Results - Earnings Call Transcript